CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 32 enrolled
Drug / intervention
Ex-PRESS® Glaucoma Filtration Device, Model P50PLdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02246777
NCT02246777N/ACompleted
CompareCT.gov

Assessment of Efficacy and Safety of the EX-PRESS® Glaucoma Filtration Device in Patients With Normal Tension Glaucoma

Alcon Research·interventional·Posted Sep 23, 2014·Updated Jul 20, 2018

In Brief

A clinical study evaluating Ex-PRESS® Glaucoma Filtration Device, Model P50PL for Glaucoma. Completed, enrolled 32 participants across 1 site.

Detailed Summary

The purpose of this study is to assess the efficacy and safety of the Alcon Ex-PRESS® Glaucoma Filtration Device (Ex-PRESS) in Japanese subjects with normal tension glaucoma.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsGlaucoma
CountriesJapan
Collaborators--

Timeline

N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedSep 23, 2014
Enrollment StartFeb 26, 2014
Primary CompletionOct 24, 2016
TodayJul 2, 2026
Enrollment to primary: 2.7 yearsPosted 11.8 years ago

Interventions

Ex-PRESS® Glaucoma Filtration Device, Model P50PLdevice